Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Fri, 23.08.2024
The Platform Group AG
The Platform Group AG: First half-year with significant growth and increase in profitability
GMV grows by 20% to EUR 442.5 million (H1 2023 pro-forma: EUR 367.3 million)
Net sales increase by 23% to EUR 231.5 million (H1 2023 pro-forma: EUR 187.5 million)
EBITDA adjusted from continuing operations up 33% to EUR 17.6 million (H1 2023 pro-forma: [ … ]
Thu, 22.08.2024
Sebastian Brunner Communications
EQS-Media / 22.08.2024 / 21:14 CET/CEST
Press Release
Lawyer Dr Michael Jaffé
Insolvency administrator for Qimonda AG, Munich
Settlement between Dr Michael Jaffé as insolvency administrator for Qimonda AG and Infineon provides for a settlement amount of 800 million euros
Conclusion of insolvency proceedings possible in 2025 with substantial [ … ]
Thu, 22.08.2024
ESGTI AG
ESGTI's Board of Directors is pleased to announce that the share split approved by the Annual General Meeting on 12 June has been completed.
For each previous share with ISIN CH0298294981 and a nominal value of CHF 1.56, 6 shares with ISIN CH1376281973 and a nominal value of CHF 0.26 will now be booked into your securities account.
The share cap [ … ]
Thu, 22.08.2024
Novem Group S.A.
Novem Group S.A.: Annual General Meeting approves all items on the agenda
Luxembourg, 22 August 2024 – The shareholders of Novem Group S.A. approved all agenda items at today’s Annual General Meeting (AGM) by a large majority. In total, 92.4% of the voting share capital was represented at the AGM.
In accordance with the proposal of the Management [ … ]
Thu, 22.08.2024
Branicks Group AG
Frankfurt am Main, August 22, 2024
Press release of the Branicks Group AG
Branicks Group AG: Annual General Meeting approves all agenda items with large majorities
Jürgen Josef Overath elected to the Supervisory Board as successor to Prof. Dr. Ulrich Reuter
Frankfurt am Main, August 22, 2024: The today’s ordinary Annual General Meeting of Bra [ … ]
Thu, 22.08.2024
Mercedes-Benz International Finance B.V.
The Interim Report 2024 as of June 30, 2024 of Mercedes-Benz International Finance B.V. is available onhttps://group.mercedes-benz.com/investors/refinancing/bonds/issuers-reports/international-finance/
This is a regulated information according to the publication requirements of the Transparency Lawand related regulations of Luxembourg.
This informa [ … ]
Thu, 22.08.2024
WEISSWERT Rechtsanwaltsgesellschaft mbH
EQS-Media / 22.08.2024 / 12:02 CET/CEST
Press release of WEISSWERT Rechtsanwaltsgesellschaft mbHInvestors Can Now Convert Gazprom ADRs Into Shares – Urgent Deadline ApproachesStuttgart, August 22, 2024
Holders of American Depositary Receipts (ADRs) from Russian companies can now mitigate potential total losses: Following the recent actions of [ … ]
Thu, 22.08.2024
Einhell Germany AG
Half year report: Einhell remains on growth path
Landau a. d. Isar, 22 August 2024 – The Einhell Group managed to significantly increase revenue in the first half of the 2024 financial year from EUR 525.9 million to EUR 576.2 million, thus continuing its growth strategy undeterred in a difficult macroeconomic environment. Main growth driver is [ … ]
Thu, 22.08.2024
Nabaltec AG
Nabaltec AG publishes interim report January to June 2024: Revenues on track in second quarter
Consolidated revenues grow in the first six months to EUR 108.4 million (+2.2%)
EBIT of EUR 10.9 million in the first six months of 2024 (first half of 2023: EUR 8.5 million)
Forecast for 2024 refined: Revenue growth of 2% to 4%, EBIT margin raised wi [ … ]
Thu, 22.08.2024
iOmx Therapeutics AG
iOmx Therapeutics Initiates Phase Ib with OMX‑0407
Data from the successful Phase Ia dose escalation study showed that OMX‑0407 monotherapy demonstrated a favorable safety profile and signs of anti-tumor activity, with one durable complete response in a high-medical-need indication
Phase Ib expansion phase in two priority indications opened
Mar [ … ]